BHF three-lens brief
Evidence-based stock research on BHF. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved +2.09% yesterday. · 50-day MA below 200-day MA (death-cross regime); price below both.
- Moved +2.09% yesterday.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- Underperforming SPY by 8.8pp over 30 days.
- P/E of 4.5 — trading at a value multiple.
- Analyst mean target $57.00 — 26% above current (6 analysts).
BHF closed at $45.33 (+2.09%) as of 2026-11-12. Market cap: $2.61B. P/E (trailing) 4.5. Price is below the 50-day MA and below the 200-day MA. Positives: moved +2.09% yesterday.; p/E of 4.5 — trading at a value multiple.. Concerns: 50-day MA below 200-day MA (death-cross regime); price below both.; underperforming SPY by 8.8pp over 30 days.. Last quarter: Revenue $2.10B, net income $302.00M, free cash flow $17.78B.
Why three lenses on BHF, not one.
A single reasoning model has blind spots it doesn’t know about. We examine BHF across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/BHF" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath BHF brief"></iframe>